title: Efficacy of immunotherapy for metastatic mucosal melanoma.
authors.affiliation: Mayo Clinic Florida, Jacksonville, FL 32224, USA.
authors.forename: Amanda
authors.initials: A
authors.lastname: Shreders
authors.affiliation: Mayo Clinic Florida, Jacksonville, FL 32224, USA.
authors.forename: Richard W
authors.initials: RW
authors.lastname: Joseph
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D000074324:Ipilimumab / Q000627:therapeutic use*; D008297:Male; D008544:Melanocytes / Q000473:pathology*; D008545:Melanoma / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D009092:Mucous Membrane / Q000473:pathology*; D009362:Neoplasm Metastasis; D009669:Nose Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology; D012878:Skin Neoplasms / Q000276:immunology / Q000473:pathology / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D000970:Antineoplastic Agents; D000074324:Ipilimumab; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor
keywords: CTLA-4; PD1; PDL1; immunotherapy; melanoma